Coca-Cola were bought by Coca-Cola in 1953. In 1885, Pemberton registered his French Wine Coca nerve tonic. In 1886, when Atlanta and Fulton County passed prohibition legislation, Pemberton responded by developing Coca-Cola, a nonalcoholic version of French Wine Coca. The first sales were at Jacob's Pharmacy in Atlanta, Georgia, on May 8, 1886. It was initially sold as a patent medicine for five cents a glass at soda fountains, which were popular in the United States at the time due to the belief that carbonated water was good for the health. Pemberton claimed Coca-Cola cured many diseases, including morphine addiction, indigestion,
Coca-Cola Hellenic Bottling Company better access to financing and a move away from crisis ridden Greece, which had prompted ratings agencies to downgrade its credit over the summer to three notches above "junk" level. On 29 April 2013 Coca-Cola HBC AG (“CCHBC AG”), the new Swiss holding company, was admitted to the London Stock Exchange’s main market. On 11 September 2013 Coca-Cola HBC AG announced its inclusion into the FTSE 100 and FTSE All-Share indices. Coca-Cola HBC was named the industry leader among beverage companies in the 2014 Dow Jones Sustainability Index. On 24 July 2014 Coca-Cola HBC AG announced its delisting of its